Q4 2021 Holdings
Filed 2022-02-14 | 87 holdings | $36.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.1M | 134,094 | 16.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $5.0M | 72,029 | 13.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.7M | 117,200 | 12.8% |
| Accuray Inc(ARAY) | COM | 004397105 | $4.5M | 941,800 | 12.2% |
| Alector Inc(ALEC) | COM | 014442107 | $3.2M | 155,247 | 8.7% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.1M | 332,103 | 8.4% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $2.3M | 313,923 | 6.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.9M | 223,554 | 5.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $1.6M | 100,135 | 4.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.5M | 11,000 | 4.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $1.1M | 206,100 | 3.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $622.0K | 196,091 | 1.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $511.0K | 136,266 | 1.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $354.0K | 30,796 | 1.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $84.8K | 13,680,554 | 0.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $22.2K | 206,911 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $21.8K | 372,160 | 0.1% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $12.8K | 733,172 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.6K | 402,667 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $11.1K | 119,615 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $10.9K | 460,061 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $9.7K | 18,138 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $9.5K | 72,423 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $8.9K | 306,320 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $8.6K | 181,467 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $8.0K | 58,100 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $7.7K | 180,306 | 0.0% |
| Merus N V | COM | N5749R100 | $7.2K | 226,089 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.1K | 83,655 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.5K | 296,535 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.2K | 40,900 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $6.0K | 1,787,569 | 0.0% |
| Cardiovascular SYS Inc(CSIIEUR) | COM | 141619106 | $5.4K | 286,988 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $5.3K | 212,231 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $4.7K | 1,764,846 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.6K | 275,976 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $4.6K | 2,200,297 | 0.0% |
| Natus MED Inc | COM | 639050103 | $4.5K | 190,635 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.9K | $4,000,000 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $3.8K | 233,500 | 0.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $3.5K | 693,785 | 0.0% |
| Affimed N V | COM | N01045108 | $3.2K | 571,282 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.5K | 190,663 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $2.5K | 54,090 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.4K | 42,675 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $2.3K | 879,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.2K | 46,452 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $2.1K | 160,983 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.1K | 447,400 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $2.0K | 289,040 | 0.0% |